Tweet
New gene treatment reveals promising future for rare blood disorder Tech Times A new gene therapy from Bluebird Bio has helped two patients suffering from beta-thalassemia. The disorder requires blood transfusions as treatment. The gene therapy eliminated those transfusions within a 12-day period of being administered. New gene therapy helps people suffering from rare blood disorderTechsonia New Gene Therapy Rapidly Helps Patients With Rare Blood DisorderForbes bluebird bio Reports Rapid Transfusion Independence in Beta-Thalassemia ...Wall Street Journal FierceBiotech -TheStreet.com all 10 news articles » |
More...